Idiopathic acute transverse myelitis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:139423G37.3
Who is this for?
Show terms as
14Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Idiopathic acute transverse myelitis (ATM) is a rare neurological disorder characterized by acute inflammation of the spinal cord that occurs without an identifiable underlying cause. The term 'idiopathic' distinguishes it from transverse myelitis that occurs secondary to known conditions such as multiple sclerosis, neuromyelitis optica spectrum disorder, systemic autoimmune diseases, or infections. The inflammation damages the myelin sheath (the protective covering of nerve fibers) and can also injure the nerve cells themselves, disrupting communication between the spinal cord and the rest of the body. The condition primarily affects the nervous system and can present with a rapid onset of motor weakness or paralysis in the legs (and sometimes arms, depending on the level of spinal cord involvement), sensory disturbances including pain, numbness, tingling, and abnormal sensitivity below the level of the lesion, as well as bowel and bladder dysfunction. Symptoms typically develop over hours to days and can range from mild to severe. A characteristic feature is a clearly defined sensory level, meaning there is a distinct boundary on the body below which sensation is altered. Back pain at the level of the inflammation is also commonly reported. There is no cure for idiopathic acute transverse myelitis, and treatment focuses on reducing spinal cord inflammation and managing symptoms. First-line therapy typically involves high-dose intravenous corticosteroids (such as methylprednisolone). For patients who do not respond adequately to steroids, plasma exchange (plasmapheresis) or intravenous immunoglobulin (IVIG) may be considered. Long-term management includes physical rehabilitation, pain management, and treatment of bladder and bowel complications. Recovery is variable: approximately one-third of patients recover well, one-third have moderate residual deficits, and one-third experience severe permanent disability. Early and aggressive treatment is associated with better outcomes.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Idiopathic acute transverse myelitis.

View clinical trials →

No actively recruiting trials found for Idiopathic acute transverse myelitis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Idiopathic acute transverse myelitis community →

Specialists

14 foundView all specialists →
QC
Qianxi Chen
Specialist
1 Idiopathic acute transverse myelitis publication
WG
Weiming Gan
Specialist
1 Idiopathic acute transverse myelitis publication
HC
Hao Chen
Specialist
1 Idiopathic acute transverse myelitis publication
JA
Jamiu Omotayo Aloba
Specialist
1 Idiopathic acute transverse myelitis publication
YZ
Yu Zhou
Specialist
1 Idiopathic acute transverse myelitis publication
XL
Xiuwen Lin
Specialist
1 Idiopathic acute transverse myelitis publication
BW
Bo Wang
Specialist
1 Idiopathic acute transverse myelitis publication
MZ
Meihong Zhou
Specialist
1 Idiopathic acute transverse myelitis publication
XW
Xiaomu Wu
Specialist
1 Idiopathic acute transverse myelitis publication
DH
Daojun Hong
Specialist
1 Idiopathic acute transverse myelitis publication
SM
Sagarika Muradia
Specialist
1 Idiopathic acute transverse myelitis publication
ZA
Zainab Afolabi
Specialist
1 Idiopathic acute transverse myelitis publication
AM
Alexandra Monaghan
OMAHA, NE
Specialist
1 Idiopathic acute transverse myelitis publication
RP
Rama Shankar Prasad
PITTSBURGH, PA
Specialist
1 Idiopathic acute transverse myelitis publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Idiopathic acute transverse myelitis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Idiopathic acute transverse myelitisForum →

No community posts yet. Be the first to share your experience with Idiopathic acute transverse myelitis.

Start the conversation →

Latest news about Idiopathic acute transverse myelitis

No recent news articles for Idiopathic acute transverse myelitis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Idiopathic acute transverse myelitis

What is Idiopathic acute transverse myelitis?

Idiopathic acute transverse myelitis (ATM) is a rare neurological disorder characterized by acute inflammation of the spinal cord that occurs without an identifiable underlying cause. The term 'idiopathic' distinguishes it from transverse myelitis that occurs secondary to known conditions such as multiple sclerosis, neuromyelitis optica spectrum disorder, systemic autoimmune diseases, or infections. The inflammation damages the myelin sheath (the protective covering of nerve fibers) and can also injure the nerve cells themselves, disrupting communication between the spinal cord and the rest of

How is Idiopathic acute transverse myelitis inherited?

Idiopathic acute transverse myelitis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Idiopathic acute transverse myelitis?

14 specialists and care centers treating Idiopathic acute transverse myelitis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.